Ringden O - Search Results

1

Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting.

Afram G, Simón JAP, Remberger M, Caballero-Velázquez T, Martino R, Piñana JL, Ringden O, Esquirol A, Lopez-Corral L, Garcia I, López-Godino O, Sierra J, Caballero D, Ljungman P, Vazquez L, Hägglund H. Afram G, et al. Among authors: ringden o. Med Oncol. 2018 Apr 25;35(6):79. doi: 10.1007/s12032-018-1127-2. Med Oncol. 2018. PMID: 29696461 Free PMC article.

2

Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients.

Aschan J, Ringdén O, Ljungman P, Lönnqvist B, Ohlman S. Aschan J, et al. Among authors: ringden o. Scand J Infect Dis. 1992;24(2):143-50. doi: 10.3109/00365549209052604. Scand J Infect Dis. 1992. PMID: 1322557

3

A comparative immunological analysis of the oral mucosa in chronic graft-versus-host disease and oral lichen planus.

Mattsson T, Sundqvist KG, Heimdahl A, Dahllöf G, Ljungman P, Ringdén O. Mattsson T, et al. Among authors: ringden o. Arch Oral Biol. 1992;37(7):539-47. doi: 10.1016/0003-9969(92)90136-v. Arch Oral Biol. 1992. PMID: 1359859

4

Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings.

Ringdén O, Klaesson S, Sundberg B, Ljungman P, Lönnqvist B, Persson U. Ringdén O, et al. Bone Marrow Transplant. 1992 Jan;9(1):19-25. Bone Marrow Transplant. 1992. PMID: 1543946

5

Alterations in taste acuity associated with allogeneic bone marrow transplantation.

Mattsson T, Arvidson K, Heimdahl A, Ljungman P, Dahllof G, Ringdén O. Mattsson T, et al. Among authors: ringden o. J Oral Pathol Med. 1992 Jan;21(1):33-7. doi: 10.1111/j.1600-0714.1992.tb00966.x. J Oral Pathol Med. 1992. PMID: 1593493

6

Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy.

Aschan J, Ringdén O, Sundberg B, Gahrton G, Ljungman P, Winiarski J. Aschan J, et al. Among authors: ringden o. Bone Marrow Transplant. 1991 Feb;7(2):113-9. Bone Marrow Transplant. 1991. PMID: 2049554 Clinical Trial.

7

Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients.

Ringdén O, Pihlstedt P, Markling L, Aschan J, Båryd I, Ljungman P, Lönnqvist B, Tollemar J, Janossy G, Sundberg B. Ringdén O, et al. Bone Marrow Transplant. 1991 Mar;7(3):221-6. Bone Marrow Transplant. 1991. PMID: 2059758 Clinical Trial.

8

Response to tetanus toxoid immunization after allogeneic bone marrow transplantation.

Ljungman P, Wiklund-Hammarsten M, Duraj V, Hammarström L, Lönnqvist B, Paulin T, Ringdén O, Pepe MS, Gahrton G. Ljungman P, et al. Among authors: ringden o. J Infect Dis. 1990 Aug;162(2):496-500. doi: 10.1093/infdis/162.2.496. J Infect Dis. 1990. PMID: 2197342

9

Markedly increased serum erythropoietin levels following conditioning for allogeneic bone marrow transplantation.

Abedi MR, Bäckman L, Boström L, Lindbäck B, Ringdén O. Abedi MR, et al. Among authors: ringden o. Bone Marrow Transplant. 1990 Aug;6(2):121-6. Bone Marrow Transplant. 1990. PMID: 2207449

10

Improved survival in marrow recipients above 30 years of age with better prevention of graft-versus-host disease.

Aschan J, Ringdén O, Tollemar J, Ljungman P, Lönnqvist B, Pihlstedt P, Markling L, Sundberg B. Aschan J, et al. Among authors: ringden o. Transplant Proc. 1990 Feb;22(1):195-7. Transplant Proc. 1990. PMID: 2309313 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

766 results

Search Page

Filters